Cryptic splice site activation by a splice donor site mutation of dystrophin intron 64 is determined by intronic splicing regulatory elements

2016 ◽  
Vol 26 ◽  
pp. S96
Author(s):  
E. Niba ◽  
A. Nishuda ◽  
V. Tran ◽  
D. Vu ◽  
M. Matsumoto ◽  
...  
1994 ◽  
Vol 302 (3) ◽  
pp. 729-735 ◽  
Author(s):  
J F Bateman ◽  
D Chan ◽  
I Moeller ◽  
M Hannagan ◽  
W G Cole

A heterozygous de novo G to A point mutation in intron 8 at the +5 position of the splice donor site of the gene for the pro alpha 1(I) chain of type I procollagen, COL1A1, was defined in a patient with type IV osteogenesis imperfecta. The splice donor site mutation resulted not only in the skipping of the upstream exon 8 but also unexpectedly had the secondary effect of activating a cryptic splice site in the next upstream intron, intron 7, leading to re-definition of the 3′ limit of exon 7. These pre-mRNA splicing aberrations cause the deletion of exon 8 sequences from the mature mRNA and the inclusion of 96 bp of intron 7 sequence. Since the mis-splicing of the mutant allele product resulted in the maintenance of the correct codon reading frame, the resultant pro alpha 1(I) chain contained a short non-collagenous 32-amino-acid sequence insertion within the repetitive Gly-Xaa-Yaa collagen sequence motif. At the protein level, the mutant alpha 1(I) chain was revealed by digestion with pepsin, which cleaved the mutant procollagen within the protease-sensitive non-collagenous insertion, producing a truncated alpha 1(I). This protease sensitivity demonstrated the structural distortion to the helical structure caused by the insertion. In long-term culture with ascorbic acid, which stimulates the formation of a mature crosslinked collagen matrix, and in tissues, there was no evidence of the mutant chain, suggesting that during matrix formation the mutant chain was unable to stably incorporated into the matrix and was degraded proteolytically.


Gene ◽  
2013 ◽  
Vol 532 (2) ◽  
pp. 297-301 ◽  
Author(s):  
Xiuyan Shi ◽  
Chunyan Ji ◽  
Lihua Cao ◽  
Yuhong Wu ◽  
Yuyang Shang ◽  
...  

2021 ◽  
Vol 22 (24) ◽  
pp. 13248
Author(s):  
John G. Conboy

A translationally silent single nucleotide mutation in exon 44 (E44) of the von Willebrand factor (VWF) gene is associated with inefficient removal of intron 44 in a von Willebrand disease (VWD) patient. This intron retention (IR) event was previously attributed to reordered E44 secondary structure that sequesters the normal splice donor site. We propose an alternative mechanism: the mutation introduces a cryptic splice donor site that interferes with the function of the annotated site to favor IR. We evaluated both models using minigene splicing reporters engineered to vary in secondary structure and/or cryptic splice site content. Analysis of splicing efficiency in transfected K562 cells suggested that the mutation-generated cryptic splice site in E44 was sufficient to induce substantial IR. Mutations predicted to vary secondary structure at the annotated site also had modest effects on IR and shifted the balance of residual splicing between the cryptic site and annotated site, supporting competition among the sites. Further studies demonstrated that introduction of cryptic splice donor motifs at other positions in E44 did not promote IR, indicating that interference with the annotated site is context dependent. We conclude that mutant deep exon splice sites can interfere with proper splicing by inducing IR.


2012 ◽  
Vol 11 (4) ◽  
pp. 559-564 ◽  
Author(s):  
Masanobu Takahashi ◽  
Yoichi Furukawa ◽  
Hideki Shimodaira ◽  
Masato Sakayori ◽  
Takuya Moriya ◽  
...  

2000 ◽  
Vol 110 (3) ◽  
pp. 694-698 ◽  
Author(s):  
C. L. Harteveld ◽  
C. Beijer ◽  
P. Van Delft ◽  
R. Zanardini ◽  
L. F. Bernini ◽  
...  

1999 ◽  
Vol 277 (2) ◽  
pp. C225-C232 ◽  
Author(s):  
Hiroyuki Nakaura ◽  
Sachio Morimoto ◽  
Fumi Yanaga ◽  
Masashi Nakata ◽  
Hirofumi Nishi ◽  
...  

A splice donor site mutation in intron 15 of the cardiac troponin T (TnT) gene has been shown to cause familial hypertrophic cardiomyopathy (HCM). In this study, two truncated human cardiac TnTs expected to be produced by this mutation were expressed in Escherichia coli and partially (50–55%) exchanged into rabbit permeabilized cardiac muscle fibers. The fibers into which a short truncated TnT, which lacked the COOH-terminal 21 amino acids because of the replacement of 28 amino acids with 7 novel residues, had been exchanged generated a Ca2+-activated maximum force that was slightly, but statistically significantly, lower than that generated by fibers into which wild-type TnT had been exchanged when troponin I (TnI) was phosphorylated by cAMP-dependent protein kinase. A long truncated TnT simply lacking the COOH-terminal 14 amino acids had no significant effect on the maximum force-generating capability in the fibers with either phosphorylated or dephosphorylated TnI. Both these two truncated TnTs conferred a lower cooperativity and a higher Ca2+ sensitivity on the Ca2+-activated force generation than did wild-type TnT, independent of the phosphorylation of TnI by cAMP-dependent protein kinase. The results demonstrate that the splice donor site mutation in the cardiac TnT gene impairs the regulatory function of the TnT molecule, leading to an increase in the Ca2+ sensitivity, and a decrease in the cooperativity, of cardiac muscle contraction, which might be involved in the pathogenesis of HCM.


Hemoglobin ◽  
2006 ◽  
Vol 30 (1) ◽  
pp. 3-7 ◽  
Author(s):  
Cornelis L. Harteveld ◽  
Max C. W. Jebbink ◽  
Nico van der Lely ◽  
Peter van Delft ◽  
Nicole Akkermans ◽  
...  

2016 ◽  
Vol 64 (5) ◽  
pp. 364 ◽  
Author(s):  
Xiuqing Zhang ◽  
Juan Bu ◽  
Sijie He ◽  
Lejin Wang ◽  
Jiankang Li ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document